Porton Pharma Solutions Ltd. (SZSE:300363) agreed to acquire 30% stake in Hubei Yuyang Pharmaceutical Co., Ltd. for CNY73.5 million on August 17, 2023. This has been approved by the Porton Pharma Solutions Ltd. (SZSE:300363) 5th directorate during its 18th meeting held on August 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.41 CNY | -3.12% | +3.57% | -30.78% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.78% | 1.36B | |
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+3.73% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.68% | 168B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Porton Pharma Solutions Ltd. agreed to acquire 30% stake in Hubei Yuyang Pharmaceutical Co., Ltd. for CNY73.5 million.